Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platinum dose-intensity

G Los1

  • 1Molecular Pharmacology Laboratory, UCSD Cancer Center, La Jolla 92093-0812, USA.

The Journal of Infusional Chemotherapy
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

High-dose platinum chemotherapy shows promise for certain cancers. Optimizing platinum dose-intensity, especially with novel approaches like intra-arterial cisplatin, may improve treatment efficacy in platinum-sensitive tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules.

British journal of cancer·2014
Same author

Association between hsp60 messenger-RNA levels and Cisplatin resistance in human head and neck-cancer cell-lines.

International journal of oncology·2011
Same author

mRNA levels of molecular chaperones hsp27, hsp60 and hsp70 in cisplatin resistant squamous cell carcinomas.

International journal of oncology·2011
Same author

Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin.

British journal of cancer·2001
Same author

Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents.

Head & neck·2001
Same author

Noninvasive, in-situ measurement of drug concentrations in tissue using optical spectroscopy.

Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology·2001
Same journal

Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.

The Journal of infusional chemotherapy·1996
Same journal

Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.

The Journal of infusional chemotherapy·1996
Same journal

The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.

The Journal of infusional chemotherapy·1996
Same journal

The French experience with infusional 5-FU in gastric and pancreatic cancer.

The Journal of infusional chemotherapy·1996
Same journal

Drug stability and compatibility in oncology care.

The Journal of infusional chemotherapy·1996
Same journal

Options for venous access in ambulatory care: issues in selection and management.

The Journal of infusional chemotherapy·1996
See all related articles

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Trials

Background:

  • Platinum-based chemotherapy is a cornerstone in cancer treatment.
  • Dose-intensity optimization aims to enhance therapeutic efficacy.
  • Previous studies faced limitations due to toxicity and modest survival benefits.

Purpose of the Study:

  • To evaluate the potential of high-dose platinum chemotherapy.
  • To explore novel strategies for increasing platinum dose-intensity.
  • To identify patient populations most likely to benefit from intensified platinum therapy.

Main Methods:

  • Review of pharmacologic principles, laboratory data, and clinical studies.
  • Analysis of prospective studies investigating high-dose cisplatin and carboplatin.

Related Experiment Videos

  • Evaluation of intra-arterial (IA) high-dose cisplatin with systemic neutralization.

    • Main Results:

    • High-dose carboplatin with hematopoietic support showed improved response rates but limited survival impact.
    • IA high-dose cisplatin with neutralization achieved high response rates in advanced head and neck cancer.
    • Toxicity often limited dose escalation in conventional platinum studies.

    Conclusions:

    • High-dose platinum intensity can potentially improve efficacy in platinum-sensitive tumors.
    • Novel approaches like IA cisplatin offer promising avenues for dose intensification.
    • Patient selection based on tumor sensitivity to platinum drugs is crucial for future success.